|
Originally published In Press as doi:10.1074/jbc.M002947200 on August 28, 2000
J. Biol. Chem., Vol. 275, Issue 48, 37311-37316, December 1, 2000
Large Isoform of Hepatitis Delta Antigen Activates Serum Response
Factor-associated Transcription*
Tadashi
Goto,
Naoya
Kato ,
Suzane Kioko
Ono-Nita,
Hideo
Yoshida,
Motoyuki
Otsuka,
Yasushi
Shiratori, and
Masao
Omata
From the Department of Gastroenterology, Faculty of Medicine,
University of Tokyo, 7-3-1 Hongo, Bunkyo-ku,
Tokyo, 113-8655, Japan
Hepatitis delta virus infection sometimes causes
severe and fulminant hepatitis as a coinfection or superinfection along
with the hepatitis B virus. To elucidate the underlying mechanism of injury caused by hepatitis delta virus, we examined whether two isoforms of the hepatitis delta antigen (HDAg) had any effect on five
well defined intracellular signal transduction pathways: serum response
factor (SRF)-, serum response element (SRE)-, nuclear factor B-,
activator protein 1-, and cyclic AMP response
element-dependent pathways. Reporter assays revealed that
large HDAg (LHDAg) activated the SRF- and SRE-dependent
pathways. In contrast, small HDAg (SHDAg) did not activate any of five
pathways. LHDAg enhanced the transcriptional ability of SRF without
changing its DNA binding affinity in an electrophoretic mobility shift
assay. In addition, LHDAg activated a rat SM22 promoter containing
SRF binding site and a human c-fos promoter containing SRE.
In conclusion, LHDAg, but not SHDAg, enhances SRF-associated
transcriptions. Despite structural similarities between the two HDAgs,
there are significant differences in their effects on intracellular
signal transduction pathways. These results may provide clues that will
aid in the clarification of functional differences between LHDAg and
SHDAg and the pathogenesis of delta hepatitis.
*
This study was supported in part by the Program for
Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-3-3815-5411 (ext. 33070); Fax: 81-3-3814-0021; E-mail:
kato-2im@h.u-tokyo.ac.jp.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F.-T. Liao, Y.-J. Lee, J.-L. Ko, C.-C. Tsai, C.-J. Tseng, and G.-T. Sheu
Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells
J. Gen. Virol.,
May 1, 2009;
90(5):
1124 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Huang, R.-T. Mai, and Y.-H. Wu Lee
Transcription Factor YY1 and Its Associated Acetyltransferases CBP and p300 Interact with Hepatitis Delta Antigens and Modulate Hepatitis Delta Virus RNA Replication
J. Virol.,
August 1, 2008;
82(15):
7313 - 7324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Huang, S. C. Chang, I-C. Yu, Y.-G. Tsay, and M.-F. Chang
Large Hepatitis Delta Antigen Is a Novel Clathrin Adaptor-Like Protein
J. Virol.,
June 1, 2007;
81(11):
5985 - 5994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maeda, M. Akanuma, Y. Mitsuno, Y. Hirata, K. Ogura, H. Yoshida, Y. Shiratori, and M. Omata
Distinct Mechanism of Helicobacter pylori-mediated NF-kappa B Activation between Gastric Cancer Cells and Monocytic Cells
J. Biol. Chem.,
November 21, 2001;
276(48):
44856 - 44864.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|